Nava Zisapel
Fondatore presso Rad Biomed Accelerator Ltd.
Patrimonio netto: 50 M $ in data 31/05/2024
Posizioni attive di Nava Zisapel
Società | Posizione | Inizio | Fine |
---|---|---|---|
Rad Biomed Accelerator Ltd.
Rad Biomed Accelerator Ltd. Investment ManagersFinance Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel. | Presidente | 01/01/1992 | - |
Fondatore | 01/01/1992 | - | |
Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Amministratore Delegato | 01/01/1991 | - |
Fondatore | 01/01/1991 | - | |
Moebius Medical Ltd.
Moebius Medical Ltd. Medical SpecialtiesHealth Technology Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel. | Direttore/Membro del Consiglio | - | - |
Vectorious Medical Technologies Ltd.
Vectorious Medical Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel. | Direttore/Membro del Consiglio | 12/03/2018 | - |
Storia della carriera di Nava Zisapel
Precedenti posizioni note di Nava Zisapel
Società | Posizione | Inizio | Fine |
---|---|---|---|
RADCOM | Fondatore | 05/07/1985 | - |
Formazione di Nava Zisapel
Tel-Aviv University | Doctorate Degree |
Statistiche
Distribuzione geografica
Israele | 7 |
Posizioni
Founder | 3 |
Director/Board Member | 2 |
Chairman | 1 |
Settori
Health Technology | 3 |
Technology Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RADCOM | Technology Services |
Aziende private | 4 |
---|---|
Rad Biomed Accelerator Ltd.
Rad Biomed Accelerator Ltd. Investment ManagersFinance Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel. | Finance |
Moebius Medical Ltd.
Moebius Medical Ltd. Medical SpecialtiesHealth Technology Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Health Technology |
Vectorious Medical Technologies Ltd.
Vectorious Medical Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel. | Electronic Technology |
- Borsa valori
- Insiders
- Nava Zisapel
- Esperienza